Thrombosis and fibrinolysis in atherosclerotic cardiovascular disease: it takes two to tango

Eur Heart J. 2022 Mar 7;43(10):982-984. doi: 10.1093/eurheartj/ehab710.

Authors

Artur Fedorowski^{1

2}, Jolanta M Siller-Matula^{3

4}, Giuseppe Patti⁵

Affiliations

¹ Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden.
² Department of Clinical Sciences, Lund University, Malmö, Sweden.
³ Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Austria.
⁴ Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Warsaw, Poland.
⁵ University of Eastern Piedmont, Department of Thoracic and Cardiovascular Diseases, Maggiore della Carità Hospital, Novara, Italy.

PMID: 34686876
DOI: 10.1093/eurheartj/ehab710

No abstract available

Publication types

Editorial
Comment

MeSH terms

Atherosclerosis* / complications
Cardiovascular Diseases*
Fibrin Clot Lysis Time
Fibrinolysis
Humans
Thrombosis*